6:30 AM SIGN-IN & BREAKFAST • 7:00 AM - 8:30 AM
BANDOL 1 (NEW WYNN SPACE)
CE: Pulmonary Arterial Hypertension: Advancements to Optimize Treatment
Pulmonary arterial hypertension (PAH) is a chronic, progressive illness that carries a poor prognosis. Over the past decade, treatment approaches have evolved and now include oral, inhaled, intravenous, and subcutaneous delivery methods. Patients diagnosed with this illness must navigate many drug-related issues and a coordinated, interdisciplinary approach is crucial to optimize outcomes. Specialty pharmacists are positioned as a liaison between the patient and provider and are critical in facilitating access and providing treatment monitoring and education. This activity will enhance pharmacists’ understanding of the current treatment paradigm, highlight recent CHEST guideline updates, and provide operational strategies to improve care for patients with PAH.